ELN.DE - Elanix Biotechnologies AG

XETRA - XETRA Delayed Price. Currency in EUR
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue6.226---
Cost of Revenue43.97512.142--
Gross Profit-37.749-12.142--
Operating Expenses
Research Development----
Selling General and Administrative----
Non Recurring----
Total Operating Expenses1,078.004623.13634.868166.7
Operating Income or Loss-1,071.778-623.136-34.868-166.7
Income from Continuing Operations
Total Other Income/Expenses Net----
Earnings Before Interest and Taxes-1,071.778-623.136-34.868-166.7
Interest Expense-23.582-8.752-8.752-0.012
Income Before Tax----
Income Tax Expense-454.878-382.706--
Minority Interest----
Net Income From Continuing Ops----
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-1,890.635-2,788.57-14.868-124.061
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares----